A Trial to Evaluate the Safety and Efficacy of NK Cells in Subjects With Myelodysplastic Syndromes
Clinical trial NCT05371730 · UNKNOWN
Trial details
- NCT number
- NCT05371730
- Sponsor
- Nuwacell Biotechnologies Co., Ltd.
- Status
- UNKNOWN
- Phase
- Early Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2022-05-30
- Primary completion
- 2025-05-30
- Enrollment
- 15
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.